Video

Q&A With Brian Kestenbaum From University of Washington: Fibroblast Growth Factor 23 May Play Key Role in Future Disease Treatment

Author(s):

While everyone has the fibroblast 23 hormone there has been some research into whether it can be linked to diseases and other conditions that can make some people sick.

While everyone has the fibroblast growth factor 23 hormone there has been some research into whether it can be linked to diseases and other conditions that can make some people sick.

Brian Kestenbaum, MD, MS, from the University of Washington discussed some of the early research on the hormone during the AACE's 24th Annual Scientific and Clinical Congress. Kestenbaum said the main role appears to be helping kidneys clear phosphates from the body. The question being investigated is whether it is tied to other more serious conditions like kidney disease and what can be done to help those patients. Even as more is learned about the role of the hormone in the body Kestenbaum said there is nothing that can be done to reverse the negative effects it has on the body.

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
© 2024 MJH Life Sciences

All rights reserved.